书签 分享 收藏 举报 版权申诉 / 3
1

类型[20160829]IF10463_非处方药监管.pdf

  • 上传人:任**
  • 文档编号:25935
  • 上传时间:2022-06-24
  • 发布时间:2019-06-25
  • 格式:PDF
  • 页数:3
  • 大小:418.24KB
  • https:/crsreports.congress.gov August 29, 2016Regulation of Over-the-Counter (OTC) DrugsThe Food and Drug Administration (FDA) regulates the safety and effectiveness of drug products sold in the United States. FDAs regulatory authority covers both prescription and nonprescription (i.e., over-the-counter, or OTC) drugs, among other things. Legislative Background The Pure Food and Drug Act of 1906 prohibited the interstate commerce of adulterated and misbranded drugs, but it did not provide FDA with the authority to review and approve products before they enter the market. Thus, drugs introduced between 1906 and 1938 were considered “pure” but with unknown safety and effectiveness. In 1938, Congress passed the Federal Food, Drug, and Cosmetic Act (FFDCA), which authorized FDA to regulate the safety of drug products sold in the United States. In 1951, the FFDCA was amended to include a prescription-only category of drugs. While prescription drugs require health practitioner supervision (due to drug toxicity, potential harmful effect, and/or method of use), OTC drugs can be used without a prescribers authorization, provided that they have an acceptable safety margin, low potential for
    展开阅读全文
    特殊限制:

    部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。

    关 键  词:
    20160829 IF10463_ 非处方药 监管
    1
    提示  联参智库所有资源均是用户自行上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作他用。
    关于本文
    本文标题:[20160829]IF10463_非处方药监管.pdf
    链接地址:https://www.lianhezuozhan.com/doc/25935.html
    1

    客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



    联参智库